piracetam has been researched along with Sjogren's Syndrome in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
Excerpt | Relevance | Reference |
---|---|---|
"However, dystonia was dramatically improved by a treatment with corticosteroids." | 1.34 | Orofacial dystonia related to Sjogren's syndrome. ( Bonakis, A; Kalfakis, N; Kontaxis, T; Papageorgiou, SG, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Papageorgiou, SG | 1 |
Kontaxis, T | 1 |
Bonakis, A | 1 |
Kalfakis, N | 1 |
1 other study available for piracetam and Sjogren's Syndrome
Article | Year |
---|---|
Orofacial dystonia related to Sjogren's syndrome.
Topics: Adrenal Cortex Hormones; Brain; Clonazepam; Dystonia; Dystonic Disorders; Face; Female; Humans; Leve | 2007 |